The method for preparing gynostemma pentaphyllum extract with increasing damulin a and damulin b contents, and a pharmaceutical compositions of the same for treating metabolic disease
KR20100055058A
The composition for the treatment of diabetes and metabolic syndrome containing synthesized obovatol and its derivatives
KR100909572B1
The composition for the treatment of diabetes and metabolic syndrome containing obovatol and its synthesized derivatives
KR20090016804A
Novel benzyl ester compounds and the composition comprising the same for preventing and treating of obesity, diabetes and hyperlipidemia
KR20080003931A
Treatment of insulin resistance syndrome
KR20050095010A
Composition containing baekangjam extract
KR20050093009A
Composition for curing atopy and cosmetics containing the composition for curing atopy
KR20040009637A
A alkaloide-based compound having potent inhibiting activity for platelet aggregation
KR20040008014A
Extracts of piper longum having potent inhibitory effect on platelet aggregation and uses thereof
KR20040003668A
A alkaloide-based compound having potent inhibiting activity for platelet aggregation
KR20030095748A
Functional kimchi having anticancer, antioxidation and antiaging activity and a method for preparing the same
KR20030057223A
A quinoline alkaloide derivative and a pharmaceutical composition comprising the same
CN1524122A
Isocitrate dehydrogenase, gene thereof, and use of the same in the treatment of obesity, hyperlipidemia, and fatty liver in lipid biosynthesis
WO0218594A1
ZEBRAFISH HuC PROMOTER CAPABLE OF DIRECTING NEURON-SPECIFIC EXPRESSION OF STRUCTURAL GENES, TRANSGENIC ANIMAL HAVING HuC PROMOTER AND ITS GENERATION, AND METHOD FOR SCREENING NEURONAL MUTANT ANIMALS USING THE TRANSGENIC ANIMAL
AU7281201A
Isocitrate dehydrogenases, their genes, and use in antioxidative system suppressive of ros-mediated diseases
KR20020096368A
Mass cell production method of chondrocytes by the inhibition of de-differentiation and a method for screening it
KR20020096367A
Pharmaceutical composition for the prevention and treatment of arthritis having effect of essential treatment and a method for screening it
KR20020095553A
Pharmaceutical composition for prevention or treatment of obesity, hyperlipidemia or fatty liver containing inhibitors of isocitrate dehydrogenase activity
